On Saturday September 23, 2017 the University of British Columbia and the Vancouver Prostate Centre’s Prostate Cancer Supportive Care Program will be participating in the 17th Annual Pacific Northwest Prostate Cancer Symposium. Click here to see the agenda (PDF opens in new tab). In conjunction with the OHSU Knight Cancer Institute and the University of Washington School of Medicine, this live symposium is for patients, their families and health care professionals...
The Journal of the National Cancer Institute today published a landmark multi-institutional study describing the first comprehensive comparison of blood-based tumour biopsy versus metastatic tissue biopsy for lethal prostate cancer.
Congratulations to Drs. Collins, Daugaard & Wang on being awarded five-year grants in the CIHR Project Grant: Fall 2016 competition. Dr. Wang is also a co-investigator on a five-year grant awarded to Dr. He at University Health Network (Toronto). Congratulations also to Dr. William Morris of the BC Cancer Agency and his research team, including our Centre's Dr. Alan So, on being awarded a six-year grant in the same competition.
UBC Media release: April 20, 2017
A drug created from a malaria protein stopped tumour growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.
Friday, April 7, 2017 9:45 AM
Research excellence at the Vancouver Prostate Centre was demonstrated at the American Association for Cancer Research (AACR) annual meeting, April 1 - 5, 2017.
Dr. Alastair Davies & Dr. Amina Zoubeidi present their work in the Tumor Stem Cell Biology session (April 4, 2017), in a talk titled "EZH2 reprogramming confers intrinsic stem cell properties and developmental plasticity driving neuroendocrine prostate cancer".
A study led by Drs. Kim Chi & Alex Wyatt demonstrated that metastatic castration-resistant prostate cancer patients with germline DNA repair defects respond poorly to androgen receptor-targeted therapy.
Congratulations to Dr. Martin Gleave on being selected to receive the 2017 Richard D. Williams, MD Prostate Cancer Research Excellence Award, which will be presented at the 2017 American Urological Association meeting.
The Urology Care Foundation, the official Foundation of the American Urological Association, presents this prestigious award to individuals for their outstanding and impactful research in the field of prostate cancer over the last 10 years.
Congratulations to Dr. S. Larry Goldenberg on winning the American Urological Society's 2017 Hugh Hampton Young Award. He received this for outstanding contributions in the study and treatment of prostatic diseases, and spearheading the development and implementation of a national men's health program. The Hugh Hampton Young Award has been presented annually since 1969 to an individual for outstanding contri
NEPC is a highly aggressive cancer that sometimes emerges in prostate cancer patients undergoing androgen deprivation therapy (ADT). Unfortunately ADT, which is common treatment for prostate cancer, had led to a correlating increase in cases of an aggressive variant called treatment-induced NEPC.